The week in review

It’s been a busy week in community pharmacy…

While Mylan Australia has advised that EpiPen Jr is no longer in shortage, it’s taking a while for supplies to reach end users, says Allergy and Anaphylaxis Australia chief executive Maria Said. Also under media scrutiny was the Pharmacy Guild and its political influence, with Crikey taking a look into the organisation’s dealings with politicians.

The PSA‘s WA branch told us about three ways pharmacists can help boost Australians’ health, in its pre-Budget submission; and the SHPA revealed four central tenets of optimal aged care.

In Canada, leading pharmacists looked at autonomous pharmacist prescribing. The RACGP called for the implementation of pandemic planning, centring GPs, though the PSA’s Chris Freeman pointed out that pharmacists also have a key role.

EBOS told us about strong growth in the first half of the year, boosted by its new deal with Chemist Warehouse. Guardian Pharmacy took out the title of Roy Morgan chemist/pharmacy of the year. And the term ‘Ramsay Pharmacyhas finally been approved as a trade mark by a privately-owned subsidiary company of Ramsay Health Care.

Social researchers say Sydney needs another safe injecting room. We discovered how many Victorians had accessed Voluntary Assisted Dying.

And we’d also like to look at whether pharmacy’s patients are becoming increasingly difficult… and whether that’s only a problem for pharmacy, or for retail more widely. Tell us how abuse from patients has affected you in our poll, here.

Previous Shortcomings exposed
Next What’s your pandemic plan?

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply